8 results on '"Scholze, M."'
Search Results
2. S01-01 Risk assessment of complex chemical mixtures – an overview of approaches and recent developments.
- Author
-
Vinggaard, A.M., Escher, B.I., Scholze, M., Valente, M.J., Lamoree, M., Hamers, T., Schmeisser, S., and Herzler, M.
- Subjects
- *
RISK assessment , *MIXTURES - Published
- 2024
- Full Text
- View/download PDF
3. S01-02 Whole mixture assessments of water, food and human blood.
- Author
-
Escher, B., Antignac, J.-P., Audebert, M., Cenjin, P., Hamers, T., Valente, M. João Portugal Couto, Khoury, L., König, M., Lamoree, M., Lee, J., Ma, Y., Jornet, M. Margalef, Motteau, S., Renko, K., Scholze, M., and Vinggaard, A.M.
- Subjects
- *
MIXTURES , *HUMAN beings - Published
- 2024
- Full Text
- View/download PDF
4. P25-04 Antiandrogenic activity of reconstituted chemical mixtures reflecting real-life co-exposure patterns.
- Author
-
Valente, M.J., Motteau, S., Margalef, M., König, M., Lee, J., Braun, G., Wojtyisiak, N., Antignac, J.-P., Lamoree, M., Scholze, M., Escher, B.I., and Vinggaard, A.M.
- Subjects
- *
MIXTURES - Published
- 2024
- Full Text
- View/download PDF
5. Two novel in vitro assays to screen chemicals for their capacity to inhibit thyroid hormone transmembrane transporter proteins OATP1C1 and OAT4.
- Author
-
Wagenaars F, Cenijn P, Chen Z, Meima M, Scholze M, and Hamers T
- Subjects
- Humans, Fluorocarbons toxicity, Thyroid Hormones metabolism, Caprylates toxicity, Thyroxine metabolism, Biological Transport drug effects, HEK293 Cells, Alkanesulfonic Acids toxicity, Animals, Endocrine Disruptors toxicity, Organic Anion Transporters metabolism, Organic Anion Transporters antagonists & inhibitors, Organic Anion Transporters, Sodium-Independent metabolism
- Abstract
Early brain development depends on adequate transport of thyroid hormones (THs) from the maternal circulation to the fetus. To reach the fetal brain, THs have to cross several physiological barriers, including the placenta, blood-brain-barrier and blood-cerebrospinal fluid-barrier. Transport across these barriers is facilitated by thyroid hormone transmembrane transporters (THTMTs). Some endocrine disrupting chemicals (EDCs) can interfere with the transport of THs by THTMTs. To screen chemicals for their capacity to disrupt THTMT facilitated TH transport, in vitro screening assays are required. In this study, we developed assays for two THTMTs, organic anion transporter polypeptide 1C1 (OATP1C1) and organic anion transporter 4 (OAT4), both known to play a role in the transport of THs across barriers. We used overexpressing cell models for both OATP1C1 and OAT4, which showed an increased uptake of radiolabeled T4 compared to control cell lines. Using these models, we screened various reference and environmental chemicals for their ability to inhibit T4 uptake by OATP1C1 and OAT4. Tetrabromobisphenol A (TBBPA) was identified as an OATP1C1 inhibitor, more potent than any of the reference chemicals tested. Additionally perfluorooctanesulfonic acid (PFOS), perfluoroctanic acid (PFOA), pentachlorophenol and quercetin were identified as OATP1C1 inhibitors in a similar range of potency to the reference chemicals tested. Bromosulfophthalein, TBBPA, PFOA and PFOS were identified as potent OAT4 inhibitors. These results demonstrate that EDCs commonly found in our environment can disrupt TH transport by THTMTs, and contribute to the identification of molecular mechanisms underlying TH system disruption chemicals., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
6. Screening for endocrine disrupting chemicals inhibiting monocarboxylate 8 (MCT8) transporter facilitated thyroid hormone transport using a modified nonradioactive assay.
- Author
-
Wagenaars F, Cenijn P, Scholze M, Frädrich C, Renko K, Köhrle J, and Hamers T
- Subjects
- Biological Transport drug effects, Phenols toxicity, Thyroxine, Humans, Animals, Dogs, Madin Darby Canine Kidney Cells, Toxicity Tests, Endocrine Disruptors isolation & purification, Endocrine Disruptors toxicity, Monocarboxylic Acid Transporters antagonists & inhibitors, Symporters antagonists & inhibitors
- Abstract
Early neurodevelopmental processes are strictly dependent on spatial and temporally modulated of thyroid hormone (TH) availability and action. Thyroid hormone transmembrane transporters (THTMT) are critical for regulating the local concentrations of TH, namely thyroxine (T4) and 3,5,3'-tri-iodothyronine (T3), in the brain. Monocarboxylate transporter 8 (MCT8) is one of the most prominent THTMT. Genetically induced deficiencies in expression, function or localization of MCT8 are associated with irreversible and severe neurodevelopmental adversities. Due to the importance of MCT8 in brain development, studies addressing chemical interferences of MCT8 facilitated T3 uptake are a crucial step to identify TH system disrupting chemicals with this specific mode of action. Recently a non-radioactive in vitro assay has been developed to rapidly screen for endocrine disrupting chemicals (EDCs) acting upon MCT8 mediated transport. This study explored the use of an UV-light digestion step as an alternative for the original ammonium persulfate (APS) digestion step. The non-radioactive TH uptake assay, with the incorporated UV-light digestion step of TH, was then used to screen a set of 31 reference chemicals and environmentally relevant substances to detect inhibition of MCT8-depending T3 uptake. This alternative assay identified three novel MCT8 inhibitors: methylmercury, bisphenol-AF and bisphenol-Z and confirmed previously known MCT8 inhibitors., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interests., (Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. M-FISH evaluation of chromosome aberrations to examine for historical exposure to ionising radiation due to participation at British nuclear test sites.
- Author
-
Lawrence KJ, Scholze M, Seixo J, Daley F, Al-Haddad E, Craenen K, Gillham C, Rake C, Peto J, and Anderson R
- Subjects
- Humans, Aged, Radiation, Ionizing, Biological Assay, Family, Chromosome Aberrations, Military Personnel
- Abstract
Veterans of the British nuclear testing programme represent a population of ex-military personnel who had the potential to be exposed to ionising radiation through their participation at nuclear testing sites in the 1950s and 1960s. In the intervening years, members of this population have raised concerns about the status of their health and that of their descendants, as a consequence. Radiation dose estimates based on film badge measurements of external dose recorded at the time of the tests suggest any exposure to be limited for the majority of personnel, however, only ∼20% of personnel were monitored and no measurement for internalised exposure are on record. Here, to in-part address families concerns, we assay for chromosomal evidence of historical radiation exposure in a group of aged nuclear test (NT) veterans, using multiplex in situ hybridisation (M-FISH), for comparison with a matched group of veterans who were not present at NT sites. In total, we analysed 9379 and 7698 metaphase cells using M-FISH (24-colour karyotyping) from 48 NT and 38 control veteran samples, representing veteran servicemen from the army, Royal Airforce and Royal Navy. We observed stable and unstable simple- and complex-type chromosome aberrations in both NT and control veterans' samples, however find no significant difference in yield of any chromosome aberration type between the two cohorts. We do observe higher average frequencies of complex chromosome aberrations in a very small subset of veterans previously identified as having a higher potential for radiation exposure, which may be indicative of internalised contamination to long-lived radionuclides from radiation fallout. By utilising recently published whole genome sequence analysis data of a sub-set of the same family groups, we examined for but found no relationship between paternal chromosome aberration burden, germline mutation frequency and self-reported concerns of adverse health in family members, suggesting that the previously reported health issues by participants in this study are unlikely to be associated with historical radiation exposure. We did observe a small number of families, representing both control and NT cohorts, showing a relationship between paternal chromosome aberrations and germline mutation sub-types which should be explored in future studies. In conclusion, we find no cytogenetic evidence of historical radiation exposure in the cohort of nuclear veterans sampled here, offering reassurance that attendance at NTs sites by the veterans sampled here, was not associated with significant levels of exposure to radiation., (Creative Commons Attribution license.)
- Published
- 2024
- Full Text
- View/download PDF
8. Drivers of divergent assessments of bisphenol-A hazards to semen quality by various European agencies, regulators and scientists.
- Author
-
Kortenkamp A, Martin O, Iacovidou E, and Scholze M
- Subjects
- Adult, Animals, Male, Humans, Phenols toxicity, Benzhydryl Compounds toxicity, Semen Analysis, Semen
- Abstract
The downward revision of the bisphenol A (BPA) Health-based Guidance Value (HBGV) by the European Food Safety Authority (EFSA) has led to disagreements with other regulatory agencies, among them the German Federal Institute for Risk Assessment (BfR). The BfR has recently published an alternative Tolerable Daily Intake (TDI), 1000-times higher than the EFSA HBGV of 0.2 ng/kg/d. While the EFSA value is defined in relation to immunotoxicity, the BfR alternative TDI is based on declines in sperm counts resulting from exposures in adulthood. Earlier, we had used semen quality deteriorations to estimate a BPA Reference Dose (RfD) of 3 ng/kg/d for use in mixture risk assessments of male reproductive health. We derived this estimate from animal studies of gestational BPA exposures which both EFSA and BfR viewed as irrelevant for human hazard characterisations. Here, we identify factors that drive these diverging views. We find that the fragmented, endpoint-oriented study evaluation system used by EFSA and BfR, with its emphasis on data that can support dose-response analyses, has obscured the overall BPA effect pattern relevant to male reproductive effects. This has led to a disregard for the effects of gestational BPA exposures. We also identify problems with the study evaluation schemes used by EFSA and BfR which leads to the omission of entire streams of evidence from consideration. The main driver of the diverging views of EFSA and BfR is the refusal by BfR to accept immunotoxic effects as the basis for establishing an HBGV. We find that switching from immunotoxicity to declines in semen quality as the basis for deriving a BPA TDI by deterministic or probabilistic approaches produces values in the range of 2.4-6.6 ng/kg/d, closer to the present EFSA HBGV of 0.2 ng/kg/d than the BfR TDI of 200 ng/kg/d. The proposed alternative BfR value is the result of value judgements which erred on the side of disregarding evidence that could have supported a lower TDI. The choices made in terms of selecting key studies and methods for dose-response analyses produced a TDI that comes close to doses shown to produce effects on semen quality in animal studies and in human studies of adult BPA exposures., Competing Interests: Declaration of competing interest Andreas Kortenkamp, Martin Scholze and Eleni Iacovidou declare they have no conflicts of interests. Olwenn V Martin reports a relationship with European Chemicals Agency that includes board membership and with the Food Packaging Forum that includes board membership and consulting or advisory services., (Copyright © 2023 The Authors. Published by Elsevier GmbH.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.